Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer, 10%+ Owner
-
Stock Symbol
-
INMB on Nasdaq
Mark William Lowdell - trading volume in the past year for Inmune Bio, Inc.
Holdings reported by Mark William Lowdell for Inmune Bio, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
1.51M |
$12.6M |
$8.32 |
Apr 19, 2024 |
Direct |
|
|
Option (right to buy) |
140K |
|
|
Dec 5, 2024 |
Direct |
Common Stock |
|
Option (right to buy) |
100K |
|
|
May 14, 2024 |
Direct |
Common Stock |
|
Common Stock Warrants (right to buy) |
14.4K |
|
|
Apr 19, 2024 |
Direct |
Common Stock |
|
Transactions reported by Mark William Lowdell for Inmune Bio, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.